Catalent Director Becomes USP Member

Stephen Tindal, director, Softgel Formulation and Operations for Catalent Pharma Solutions, has been accepted as a member of the United States Pharmacopoeia (USP) advisory panel focusing on liquid filled gelatin capsules. His responsibilities include working with industry experts to provide guidance on revisions to USP monographs and chapters concerning soft gelatin capsules. The Advisory Panel will work on dissolution testing of liquid filled gelatin capsules for prescription, OTC medicines, and other healthcare products.

The USP sets standards for the quality, purity, strength, and consistency of these products that are critical to the public health. The USP’s standards are recognized and used in more than 130 countries around the world.

“It is an honor to be recognized as a technical expert in the manufacture of soft gelatin capsules. Catalent’s continued commitment to the softgel technology builds on the R.P. Scherer heritage of over 75 years expertise and innovation in softgel development and manufacturing. I look forward to supporting the USP’s mission to improve the health of people around the world through public standards and related programs that help ensure the quality, safety, and benefit of medicines and foods,” said Mr. Tindal.

Mr. Tindal joins Catalent’s vice president of Quality, Mary Foster, Pharm.D., who currently serves as the chair of the USP Packaging, Storage and Distribution Expert Committee for the 2010-2015 USP cycle (PSD EC).


Visit Catalent at Contracting & Outsourcing 2010!

Click here to view the Exhibitor list in the sold out Exhibit Hall